1 The retractions came only a few months after BioMed Central.
At the end of 2014, BioMed Central and other publishers alerted the international Committee on Publication Ethics to new forms of systematic attempts to manipulate journals’ peer-review procedures. According to a declaration published on COPE’s internet site in January 2015, these attempts to hijack the scholarly review program were apparently orchestrated by agencies that initial helped authors create or enhance their scientific articles and sold them favorable peer testimonials.4 BioMed Central conducted a thorough investigation of most their recently published content articles and identified 43 that were published on the basis of reviews from fabricated reviewers.You should not assume that the info contained in the prospectus and the accompanying prospectus product is usually accurate on any time after the date set forth on the front side of these docs or that any information that the Company has incorporated by reference is appropriate on any date subsequent to the time of the document integrated by reference. The Business's business, financial condition, results of procedures and prospects may have changed since those dates.
ABRAXANE accepted for limited used in Scotland NHS Abraxis BioScience, Inc.D., Vice President, European Operations of Abraxis BioScience..